Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Income from Continuing Operations (2016 - 2026)

Apyx Medical filings provide 15 years of Income from Continuing Operations readings, the most recent being 1240000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 82.57% to 1240000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 11105000.0, a 57.31% increase, with the full-year FY2025 number at 11105000.0, up 57.31% from a year prior.
  • Income from Continuing Operations hit 1240000.0 in Q4 2025 for Apyx Medical, up from 1955000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1019000.0 in Q2 2023 to a low of 9624000.0 in Q4 2023.
  • Median Income from Continuing Operations over the past 5 years was 4699500.0 (2023), compared with a mean of 4722350.0.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 546.32% in 2024 and later surged 82.57% in 2025.
  • Apyx Medical's Income from Continuing Operations stood at 2010000.0 in 2021, then crashed by 201.74% to 6065000.0 in 2022, then crashed by 58.68% to 9624000.0 in 2023, then grew by 26.08% to 7114000.0 in 2024, then surged by 82.57% to 1240000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 1240000.0 (Q4 2025), 1955000.0 (Q3 2025), and 3738000.0 (Q2 2025) per Business Quant data.